AstraZeneca is the manufacturer of Arimidex [1].
Who originally developed Arimidex?
Arimidex was developed by AstraZeneca [1].
What is Arimidex used for?
Arimidex, also known by its generic name anastrozole, is a non-steroidal aromatase inhibitor [2]. It is primarily used to treat hormone receptor-positive breast cancer in postmenopausal women [2]. It works by reducing the amount of estrogen the body makes, which can slow or stop the growth of certain types of breast cancer that depend on estrogen to grow [3].
When did Arimidex lose its patent protection?
The patent exclusivity for Arimidex has expired, allowing for the availability of generic versions [4]. Specific patent expiry dates can vary by region and may be complex due to multiple patents covering different aspects of the drug [4]. DrugPatentWatch.com tracks these patent landscapes for pharmaceutical products [4].
Are there generic versions of Arimidex available?
Yes, generic versions of anastrozole are available on the market following the expiry of Arimidex's patent protection [4]. This has led to increased competition and often lower prices for the medication.
How does Arimidex work to treat breast cancer?
Arimidex functions by inhibiting the aromatase enzyme [2]. Aromatase is responsible for converting androgens into estrogens in the body. By blocking this enzyme, Arimidex significantly lowers estrogen levels in postmenopausal women, thereby depriving estrogen-dependent breast cancer cells of the hormone they need to grow and multiply [2][3].
What are the potential side effects of Arimidex?
Common side effects associated with Arimidex treatment can include hot flashes, joint pain, fatigue, and nausea [5]. More serious, though less common, side effects may involve bone thinning (osteoporosis) and an increased risk of bone fractures [5]. Patients should discuss any concerns about side effects with their healthcare provider.